1.13

0.89% 0.010

Pre-market: 1.13

Mustang Bio Inc (MBIO)

Overview News Price History Financials Why MBIO Down? Discussions Forecast Stock Split

Mustang Bio Inc stock is traded at $1.13, with a volume of 65,854. It is up +0.89% in the last 24 hours and down -16.91% over the past month. Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Previous Close:

$1.12

Open:

$1.12

24h Volume:

65,854

Relative Volume:

0.16

Market Cap:

$2.78M

Revenue:

Net Income/Loss:

$-23.42M

P/E Ratio:

-0.0145

EPS:

-78

Net Cash Flow:

$-16.67M

1W Performance:

-4.24%

1M Performance:

-16.91%

6M Performance:

-90.10%

1Y Performance:

-91.83%

1-Day Range:

$1.0701

$1.13

1-Week Range:

$1.07

$1.17

52-Week Range:

$1.01

$65.00

Mustang Bio Inc Stock (MBIO) Company Profile

Name

Mustang Bio Inc

Sector

Healthcare (1147)

Industry

Biotechnology (673)

Phone

(781) 652-4500

Address

377 PLANTATION STREET, WORCESTER, NY

Employee

Twitter

@Mustang_Bio

Next Earnings Date

2024-11-12

Latest SEC Filings

MBIO's Discussions on Twitter

Compare MBIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MBIO Mustang Bio Inc	1.13	3.90M	0	-23.42M	-16.67M	-78.00
ONC Beigene Ltd Adr	225.77	25.49B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	434.38	110.32B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.32	38.69M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	584.99	59.13B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	69.53	5.64B	0	-153.72M	-103.81M	-2.00

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-18-21	Initiated	BTIG Research	Buy
Oct-02-20	Initiated	B. Riley FBR	Buy
Nov-20-19	Initiated	Cantor Fitzgerald	Overweight
Aug-13-19	Initiated	H.C. Wainwright	Buy
Jun-21-19	Initiated	Cantor Fitzgerald	Overweight
Dec-21-17	Initiated	Oppenheimer	Outperform

View All

Mustang Bio Inc Stock (MBIO) Latest News

May 07, 2025

Arvinas (NASDAQ:ARVN) and Mustang Bio (NASDAQ:MBIO) Financial Contrast - Defense World

May 07, 2025

May 05, 2025

Geode Capital Management LLC Purchases 38,951 Shares of Mustang Bio, Inc. (NASDAQ:MBIO) - Defense World

May 05, 2025

Apr 28, 2025

Closing Bell Recap: Mustang Bio Inc (MBIO) Ends at 1.22, Reflecting a -1.61 Downturn - DWinneX

Apr 28, 2025

Mustang Bio stock plunges to 52-week low of $2.6 amid sharp decline - MSN

Apr 28, 2025

Apr 26, 2025

Mustang Bio stock plunges to 52-week low of $1.12 - Investing.com Australia

Apr 26, 2025

Apr 25, 2025

Mustang Bio stock plunges to 52-week low of $1.12 By Investing.com - Investing.com South Africa

Apr 25, 2025

Financial Analysis: Bio-Key International Inc (BKYI)’s Ratios Unveil Key Insights - DWinneX

Apr 25, 2025

Apr 24, 2025

Mustang Bio (MBIO) Sells Facility to AbbVie for $1 Million - GuruFocus

Apr 24, 2025

Mustang Bio Inc: Rising -98.18% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

Apr 24, 2025

Mustang Bio (MBIO) Regains Nasdaq Compliance - GuruFocus

Apr 24, 2025

Now Is The Time To Build A Position In Mustang Bio Inc (NASDAQ:MBIO) - Marketing Sentinel

Apr 24, 2025

What to expect from MBIO’s earnings report this quarter? - uspostnews.com

Apr 24, 2025

Apr 05, 2025

Mustang Bio stock hits 52-week low at $1.20 amid sharp decline - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Mustang Bio stock hits 52-week low at $1.20 amid sharp decline By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 28, 2025

Mustang Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025